Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of radiation therapy on clonal hematopoiesis
    Meeting Abstract

    Modlin, L. A.; Wijetunga, N. A.; Patel, M.; Gao, T.; Ptashkin, R.; Sullivan, M. R.; Kelly, D. W.; Caltabellotta, N.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes among older adults (OA) receiving second-line therapy for metastatic CRC (mCRC): 5,289 patients (pts) from the ARCAD Clinical Trials Program
    Meeting Abstract

    McCleary, N. J.; Harmsen, W. S.; VanCutsem, E.; Sobrero, A. F.; Goldberg, R. M.; Tabernero, J.; Seymour, M.; Saltz, L. B.; Giantonio, B. J.; Dirk, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC)
    Meeting Abstract

    Kelley, R. K.; Sangro, B.; Harris, W. P.; Ikeda, M.; Okusaka, T.; Kang, Y. K.; Qin, S.; Tai, W. M. D.; Lim, H. Y.; Yau, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer: Updated survival results from a randomized, three-arm, phase III study versus choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC)
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H. S.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes
    Meeting Abstract

    Vasiniotis Kamarinos, N.; Vakiani, E.; Gonen, M.; Kemeny, N. E.; Covey, A. M.; Brown, K. T.; Brody, L. A.; Deipolyi, A. R.; Camacho, J.; Boas, F. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of post second-line chemotherapy treatment outcomes for patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions
    Meeting Abstract

    Javle, M. M.; Sadeghi, S.; El-Khoueiry, A. B.; Goyal, L.; Philip, P. A.; Kelley, R. K.; Borbath, I.; Macarulla, T.; Yong, W. P.; Tanasanvimon, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database
    Meeting Abstract

    Jin, Z.; Dixon, J. G.; Parekh, H. D.; Alberts, S. R.; Yothers, G.; Allegra, C. J.; Kerr, R.; Haller, D. G.; De Gramont, A.; Yoshino, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial
    Meeting Abstract

    Garcia-Aguilar, J.; Patil, S.; Kim, J. K.; Yuval, J. B.; Thompson, H.; Verheij, F.; Lee, M.; Saltz, L. B.; on behalf of the OPRA Consortium
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save